“hyperCORE International is one of the premier integrated research networks in the industry and I am honored to be voted in as CEO from my peers to take on the leadership of this amazing team. In a time of uncertainty, research has a vital role in finding a solution to this pandemic and the future of research sites is changing rapidly of which hyperCORE International is poised to be leading” - Karri Venn, CEO
The collaboration between hyperCORE's alliance partner companies is reflective of an industry demand for more professionalized and efficient models for the delivery of clinical trials. Each alliance partner is thoroughly vetted prior to acceptance, reflecting hyperCORE's values in superior quality, experience, efficiency and industry leadership.
Benchmark Research is a leader in the clinical research industry with experience in Phase I-IV trials. Benchmark has five geographically diverse, multi-therapeutic research centers. Our database of over 90,000 patients gives us access to a large number of subjects, ensuring high volume patient recruitment and retention. We have enrolled over 40,000 subjects in more than 1,025 trials since our inception in 1997. Our trial experience covers a wide range of indication areas, including diagnostics, cardiovascular, infectious disease, musculoskeletal, endocrinology, women’s health, allergy and vaccines. We have conducted trials with 100+ Sponsors, providing them with unsurpassed trial execution, clean data, and a steadfast pledge to patient safety.
Clinical Trials of Texas
Clinical Trials of Texas, Inc. (CTT) was founded in 2001 to conduct pharmaceutical and device research studies with high integrity and exceptional quality realized through an outstanding group of research professionals and investigators affiliated with CTT. CTT has a highly-equipped and versatile 19,000 sq. ft. facility capable of conducting Early Phase – Phase IV studies in a multitude of therapeutic areas. CTT works with 13 board-certified physicians to conduct studies in their respective medical specialties. This network of investigators has helped create one of the largest and most capable stand-alone research sites in the United States.
Founded in 2006, DIEX Recherche is a clinical research company offering services to industries in the pharmaceutical and biotechnology fields. Concerned first and foremost with the well-being of participants, the organization conducts Phase I to IV clinical trials that meet the very strict requirements of its clients, two priorities that earned them a formidable reputation within the global medical and scientific communities. DIEX Recherche has 4 sites serving the population of Sherbrooke, Quebec, Victoriaville and Joliette. DIEX is the first Canadian research center to obtain full AAHRPP accreditation (Association for the Accreditation of Human Research Protection Programs www.aahrpp.org).
FOMAT Medical Research
FOMAT Medical Research was a spin off of Diverse Research Solutions (DRS) to expand the diversity focus. FOMAT acquired DRS six years later and established their headquarters in California. They have more than 10 years experience participating in Phase 1 through Phase 4 Clinical Trials in most therapeutic areas. FOMAT relies on a highly experienced clinical research team with professional expertise to assist sponsors and CROs in reaching their project goals quickly and effectively. All sites are pre-qualified to ensure their performance will exceed expectations, both in terms of speed and quality. Once in the network, our sites abide by established quality standards.
IACT Health strives to revolutionize research by conducting clinical trials with dedicated research professionals across the Southeast in more than 30 therapeutic areas. Every member of the team specializes in one very specific role within the company. IACT Health delivers focused care and is dedicated to creating outstanding clinical trial experiences, improving outcomes, and lowering the risk and net cost of studies. IACT Health’s proven enrollment is over 200% of the average research site, as assessed by Tufts University. Since 2005, IACT Health has contributed to helping 80 medications achieve FDA approvals in areas such as oncology, cardiology, pulmonology, endocrinology, infectious disease, and pain. IACT Health is committed to enhancing overall efficiency, speed, quality, and accuracy in today’s clinical site model.
LMC Manna Research
Canada’s leading integrated research site organization with 21 sites across Canada, LMC Manna has access to more the 1 million patients, award winning in-house patient recruitment, over 120 experienced staff and ability to use central IRB - we consistently outperform and overdeliver. Accelerated study startup often yields first patient first visit (FPFV) both nationally and globally – our sites frequently competing amongst each other in achieving this milestone. Our centralized model allows for consistent quality, improved efficiency and reduced costs across all aspects and all phases of your research. LMC Manna Research conducts research across all phases from Phase I (CPU) to Phase IV and Real World Evidence (RWE) and virtual trials.
AGA CLINICAL TRIALS
Founded in 2007, AGA Clinical Trials is a clinical research company offering services in the pharmaceutical, medical devices, and biotechnology industry. The organization conducts Phase I to IV clinical diversity trials in adult and pediatric populations in close to thirteen medical specialties. Our ACRP/SOCRA certified personnel and Investigators allow for consistent quality, improved efficiency, and reduced costs across all aspects of research. Among top enrollers for 92% of trials involved provided the recognition of IQVIA, PAREXEL, and COVANCE as a partner site. AGA Clinical Trials has contributed to helping 30 medications achieve FDA approvals since 2007.
Our US site in the Miami area, and our Ecuador, South America site is ready and pre-qualified for conducting the most rigorous trials required by the industry. Our South American site is one of the only certified institutions by NIH for vaccine trials in our country.
Clinical Site Partners
Clinical Site Partners is a multi-specialty network of highly experienced clinical research sites with Phase I-IV and device capabilities across a broad range of therapeutic areas. Our specialties include: respiratory, sleep, CNS, nephrology, endocrinology, cardiology, gastroenterology, internal medicine, and critical care. We are leaders in the respiratory and sleep research space. Additionally, we have two state-of-the-art certified Phase 1 units. All of our sites are virtual trial capable and have centralized recruitment, feasibilities, contracts/budgets, training, and project management. Our infrastructure allows us to provide our Sponsor’s and CRO’s with exceptional quality on expedited timelines for accelerated recruitment.
Quality Clinical Research:
We are a multi-specialty clinical research site in Omaha Nebraska comprised of internal medicine, colon and rectal surgeons, and infectious disease, dermatology, psychiatric, and pediatric physicians. Our physicians have over 15 years of research expertise and are board-certified in family practice, internal medicine, colon and rectal surgery, infectious disease, dermatology, psychiatry, and pediatrics. Quality Clinical Research, Inc. has conducted over 700 studies in these therapeutic areas.
MOORE Clinical Research:
Founded in 2006, MOORE Clinical Research, Inc. (MCR) is a privately owned and operated, 3 site research center located in the Tampa Bay metro area, with a proud reputation and consistent record of quality, integrity and reliability. We specialize in conducting Phase II-IV clinical trials in multi-therapeutic areas. Our team comes with over 150 years of research experience collectively and are highly trained and credentialed Board Certified MDs, Registered Nurses, Nurse Practitioners, Research Coordinators & Research Assistants with experience in Dermatology, Immunology, Internal Medicine, Neurology and Mental Health research. The experienced team at MCR is a team you can always rely on to maintain the high standards expected by the industry, to consistently follow established standards and regulations and to always deliver prompt, accurate results.